Literature DB >> 20385791

Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology.

Sophia S Wang1, Amr M Abdou, Lindsay M Morton, Rasmi Thomas, James R Cerhan, Xiaojiang Gao, Wendy Cozen, Nathaniel Rothman, Scott Davis, Richard K Severson, Leslie Bernstein, Patricia Hartge, Mary Carrington.   

Abstract

Genome-wide association and candidate gene studies implicate different genetic variants within the 6p21 chromosomal region with different non-Hodgkin lymphoma (NHL) subtypes. Complementing these efforts, we conducted human leukocyte antigen (HLA) class I and class II genotyping among 610 NHL cases and 555 controls of non-Hispanic white descent from a US multicenter study. Allele-disease associations were assessed by logistic regression for NHL and its subtypes. Statistically significant associations between HLA and NHL subtypes include HLA-DRB1*0101 for follicular lymphoma (odds ratio [OR] = 2.14, P < .001), HLA-DRB1*0401 for diffuse large B-cell lymphoma (DLBCL; OR = 0.45, P = .006), and HLA-DRB1*13 and follicular lymphoma (OR = 0.48, P = .008). We further observed significant heterozygote advantage for HLA class I alleles and NHL, and particularly DLBCL (P trend = .01 for elevated risk with increasing number of homozygous alleles). Our results support a role for HLA in the etiology of NHL and its subtypes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20385791      PMCID: PMC2890176          DOI: 10.1182/blood-2010-01-266775

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Enhanced immunological surveillance in mice heterozygous at the H-2 gene complex.

Authors:  P C Doherty; R M Zinkernagel
Journal:  Nature       Date:  1975-07-03       Impact factor: 49.962

2.  Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma.

Authors:  A M Abdou; X Gao; W Cozen; J R Cerhan; N Rothman; M P Martin; S Davis; M Schenk; S J Chanock; P Hartge; M Carrington; S S Wang
Journal:  Leukemia       Date:  2010-02-11       Impact factor: 11.528

3.  MHC class II genes influence the susceptibility to chronic active hepatitis C.

Authors:  T Höhler; G Gerken; A Notghi; P Knolle; R Lubjuhn; H Taheri; P M Schneider; K H Meyer zum Büschenfelde; C Rittner
Journal:  J Hepatol       Date:  1997-08       Impact factor: 25.083

4.  HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.

Authors:  M Carrington; G W Nelson; M P Martin; T Kissner; D Vlahov; J J Goedert; R Kaslow; S Buchbinder; K Hoots; S J O'Brien
Journal:  Science       Date:  1999-03-12       Impact factor: 47.728

5.  Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.

Authors:  Nathaniel Rothman; Christine F Skibola; Sophia S Wang; Gareth Morgan; Qing Lan; Martyn T Smith; John J Spinelli; Eleanor Willett; Silvia De Sanjose; Pierluigi Cocco; Sonja I Berndt; Paul Brennan; Angela Brooks-Wilson; Sholom Wacholder; Nikolaus Becker; Patricia Hartge; Tongzhang Zheng; Eve Roman; Elizabeth A Holly; Paolo Boffetta; Bruce Armstrong; Wendy Cozen; Martha Linet; F Xavier Bosch; Maria Grazia Ennas; Theodore R Holford; Richard P Gallagher; Sara Rollinson; Paige M Bracci; James R Cerhan; Denise Whitby; Patrick S Moore; Brian Leaderer; Agnes Lai; Charlotte Spink; Scott Davis; Ramon Bosch; Aldo Scarpa; Yawei Zhang; Richard K Severson; Meredith Yeager; Stephen Chanock; Alexandra Nieters
Journal:  Lancet Oncol       Date:  2006-01       Impact factor: 41.316

6.  HLA class II associated risk and protection against multiple sclerosis-a Finnish family study.

Authors:  Mikko Laaksonen; Tomi Pastinen; Minna Sjöroos; Satu Kuokkanen; Juhani Ruutiainen; Marja Liisa Sumelahti; Helena Reijonen; Reijo Salonen; Juhani Wikström; Martin Panelius; Jukka Partanen; Pentti J Tienari; Jorma Ilonen
Journal:  J Neuroimmunol       Date:  2002-01       Impact factor: 3.478

7.  Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus.

Authors:  N Kuzushita; N Hayashi; T Moribe; K Katayama; T Kanto; S Nakatani; T Kaneshige; T Tatsumi; A Ito; K Mochizuki; Y Sasaki; A Kasahara; M Hori
Journal:  Hepatology       Date:  1998-01       Impact factor: 17.425

8.  HLA-DRB1*1301 and *1302 protect against chronic hepatitis B.

Authors:  T Höhler; G Gerken; A Notghi; R Lubjuhn; H Taheri; U Protzer; H F Löhr; P M Schneider; K H Meyer zum Büschenfelde; C Rittner
Journal:  J Hepatol       Date:  1997-03       Impact factor: 25.083

9.  Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis.

Authors:  George W Nelson; Maureen P Martin; Dafna Gladman; Judith Wade; John Trowsdale; Mary Carrington
Journal:  J Immunol       Date:  2004-10-01       Impact factor: 5.422

10.  A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC.

Authors:  Paul I W de Bakker; Gil McVean; Pardis C Sabeti; Marcos M Miretti; Todd Green; Jonathan Marchini; Xiayi Ke; Alienke J Monsuur; Pamela Whittaker; Marcos Delgado; Jonathan Morrison; Angela Richardson; Emily C Walsh; Xiaojiang Gao; Luana Galver; John Hart; David A Hafler; Margaret Pericak-Vance; John A Todd; Mark J Daly; John Trowsdale; Cisca Wijmenga; Tim J Vyse; Stephan Beck; Sarah Shaw Murray; Mary Carrington; Simon Gregory; Panos Deloukas; John D Rioux
Journal:  Nat Genet       Date:  2006-09-24       Impact factor: 38.330

View more
  35 in total

1.  Multi-locus HLA class I and II allele and haplotype associations with follicular lymphoma.

Authors:  C F Skibola; N K Akers; L Conde; M Ladner; S K Hawbecker; F Cohen; F Ribas; H A Erlich; D Goodridge; E A Trachtenberg; M T Smith; P M Bracci
Journal:  Tissue Antigens       Date:  2012-02-02

2.  HLA*IMP--an integrated framework for imputing classical HLA alleles from SNP genotypes.

Authors:  Alexander T Dilthey; Loukas Moutsianas; Stephen Leslie; Gil McVean
Journal:  Bioinformatics       Date:  2011-02-07       Impact factor: 6.937

Review 3.  Host genetics in follicular lymphoma.

Authors:  James R Cerhan
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-05       Impact factor: 3.020

4.  SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma.

Authors:  David Wrench; Pamela Leighton; Christine F Skibola; Lucia Conde; Jean-Baptiste Cazier; Janet Matthews; Sameena Iqbal; Emanuela Carlotti; Csaba Bödör; Silvia Montoto; Maria Calaminici; John G Gribben; T Andrew Lister; Jude Fitzgibbon
Journal:  Blood       Date:  2011-01-13       Impact factor: 22.113

5.  Fine-mapping of HLA associations with chronic lymphocytic leukemia in US populations.

Authors:  Loren Gragert; Stephanie Fingerson; Mark Albrecht; Martin Maiers; Matt Kalaycio; Brian T Hill
Journal:  Blood       Date:  2014-09-17       Impact factor: 22.113

6.  Association of HLA-DQB1 alleles with risk of follicular lymphoma.

Authors:  Nicholas K Akers; John D Curry; Lucia Conde; Paige M Bracci; Martyn T Smith; Christine F Skibola
Journal:  Leuk Lymphoma       Date:  2010-12-06

7.  Class II human leucocyte antigen DRB1*11 in hairy cell leukaemia patients with and without haemolytic uraemic syndrome.

Authors:  Evgeny Arons; Sharon Adams; David J Venzon; Ira Pastan; Robert J Kreitman
Journal:  Br J Haematol       Date:  2014-06-13       Impact factor: 6.998

8.  The immunodominant influenza A virus M158-66 cytotoxic T lymphocyte epitope exhibits degenerate class I major histocompatibility complex restriction in humans.

Authors:  Joanna A L Choo; Jingxian Liu; Xinyu Toh; Gijsbert M Grotenbreg; Ee Chee Ren
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

9.  HLA polymorphism and risk of multiple myeloma.

Authors:  Meral Beksac; Loren Gragert; Stephanie Fingerson; Martin Maiers; Mei-Jie Zhang; Mark Albrecht; Xiaobo Zhong; Wendy Cozen; Angela Dispenzieri; Sagar Lonial; Parameswaran Hari
Journal:  Leukemia       Date:  2016-07-27       Impact factor: 11.528

10.  A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.

Authors:  James R Cerhan; Zachary S Fredericksen; Anne J Novak; Stephen M Ansell; Neil E Kay; Mark Liebow; Ahmet Dogan; Julie M Cunningham; Alice H Wang; Thomas E Witzig; Thomas M Habermann; Yan W Asmann; Susan L Slager
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-08-21       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.